A detailed history of Rathbones Group PLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Rathbones Group PLC holds 4,260 shares of UTHR stock, worth $1.65 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,260
Previous 4,260 -0.0%
Holding current value
$1.65 Million
Previous $1.36 Million 12.45%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$211.82 - $248.24 $902,353 - $1.06 Million
4,260 New
4,260 $962,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Rathbones Group PLC Portfolio

Follow Rathbones Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.